This month, the Association for Molecular Pathology (AMP) released the results of its cost analysis and health economic–evaluation models for a number of genomic sequencing–procedure (GSP) CPT codes. The organization also released a template tool for molecular-diagnostic labs to determine the costs of their next-generation sequencing (NGS) assays for GSPs. The AMP performed the analysis […]
This spring, the National Cancer Institute will fund a program called Match to test the effects of a dozen or more new drugs on thousands of patients’ tumors. These so-called basket studies would group tumors from different types of cancers together, and a specific drug would be administered to patients possessing the same mutation. This […]
Last month, India’s 2015–16 budget was announced. The Ministry of Science Technology would receive INR 9,492 crore ($1,535 million), gaining 22.6% compared with figures from the revised fiscal 2015 budget. Within the Ministry, the Departments of Science and Technology, Biotechnology, and Scientific and Industrial Research would receive INR 3,836 crore ($621 million), INR 1,626 crore […]
Waltham, MA 1/21/15—Repligen, a provider of consumables products for manufacturing biological drugs, has appointed COO Tony J. Hunt as CEO, effective May 21. He succeeds Walter C. Herlihy, PhD, who will retire as president and CEO. “We are delighted to promote our COO, Tony Hunt, a seasoned and successful bioprocessing-industry executive, to the position of […]
This month, the FDA approved the first biosimilar drug in the US—Novartis’s Zarxio. An approximate copy of Amgen’s biologic drug Neupogen for increasing the white-blood-cell counts of cancer patients, Zarxio’s approval for all of Neupogen’s uses leads the way for competition and lower prices for biologics in the US. With the FDA now authorized to […]
Fourth quarter 2014 IBO Life Science Index sales grew 7.3%, 9.0% organically, to $4,317 million, marking its strongest organic growth since the first quarter of 2010. Growth was driven by demand from US pharmaceutical and biotechnology customers, increased research spending in Europe and positive demand in China. However, delayed spending in Japan and weak academic […]
Burgdorf, Switzerland 2/23/15—ReseaChem, a German provider of chemical services and isotope and laboratory supplies, has acquired Swiss firm ACL Instruments for an undisclosed amount. ACL provides solutions for the characterization of long-term oxidative reactions in solids and liquids, including instrumentation and services. ReseaChem stated that the acquisition was part of an effort to diversify its […]
Washington, DC 3/3/15—OpGen has filed for an IPO of its common stock on the NASDAQ Stock Market. OpGen provides the Acuitas multidrug-resistant organism (MDRO)–focused products for rapidly identifying infections in hospital patients and the Argus Whole Genome Mapping system. In 2014, sales increased 71.1% to $4.1 million (see page 12) due to increased collaboration revenue. […]
Waltham, MA 2/17/15—PerkinElmer has announced a chromatography collaboration with Waters, under which its LC and GC portfolio will be standardized on Waters Empower Software chromatography data system. “Our alliance with Waters combines cutting-edge chromatography technologies and sophisticated analysis software with leading application knowledge and best-in-class services,” stated Jon DiVincenzo, president of Environmental Health, PerkinElmer. PerkinElmer […]
Washington, DC 2/27/15; Billerica, MA 3/2/15—RainDance Technologies has filed with the SEC for a proposed IPO of its common stock on the NASDAQ Stock Market under the symbol “RAIN.” The company develops, manufactures and sells systems based on its digital droplet technology as well as consumables and assays for the detection and analysis of complex […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
